Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. - Wikidata - awgldk - TriplyDB

Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes.

Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes.

http://www.wikidata.org/entity/Q36755303

about

Regulation of glucose homeostasis by GLP-1 Mechanism Underlying the Weight Loss and Complications of Roux-en-Y Gastric Bypass. Review Mechanisms of Weight Regain following Weight Loss Clues from bariatric surgery: reversing insulin resistance to heal the heart Effects of glucagon like peptide-1 to mediate glycemic effects of weight loss surgery Metabolic surgery: action via hormonal milieu changes, changes in bile acids or gut microbiota? A summary of the literature Effects of GLP-1 on appetite and weight Relationship between gut hormones and glucose homeostasis after bariatric surgery Do we really know why diabetes remits after gastric bypass surgery?Mineral malnutrition following bariatric surgery Differences in Weight Loss and Gut Hormones: Rouen-Y Gastric Bypass and Sleeve Gastrectomy Surgery.Obesity and the need for bariatric surgery in Pakistan.The neurohormonal regulation of energy intake in relation to bariatric surgery for obesity Changes in neurohormonal gut peptides following bariatric surgery.Diabetes resolution and hyperinsulinaemia after metabolic Roux-en-Y gastric bypass.Surgical treatment of type 2 diabetes: the surgeon perspective.Prevalence of and risk factors for hypoglycemic symptoms after gastric bypass and sleeve gastrectomy Hormonal response to a mixed-meal challenge after reversal of gastric bypass for hypoglycemia Bariatric surgery reduces oxidative stress by blunting 24-h acute glucose fluctuations in type 2 diabetic obese patients.Altered islet function and insulin clearance cause hyperinsulinemia in gastric bypass patients with symptoms of postprandial hypoglycemia The environment within: how gut microbiota may influence metabolism and body composition.Bariatric Surgery and Liver Transplantation Effect of gastric bypass surgery on the incretins Effect of weight loss by diet or gastric bypass surgery on peptide YY3-36 levels.The sum of many parts: potential mechanisms for improvement in glucose homeostasis after bariatric surgery Meal-induced hormone responses in a rat model of Roux-en-Y gastric bypass surgery.Do Incretins play a role in the remission of type 2 diabetes after gastric bypass surgery: What are the evidence?β-cell function after weight-loss induced by bariatric surgery.Bariatric surgery and obesity: influence on the incretins Roux-en-Y gastric bypass promotes expression of PDX-1 and regeneration of beta-cells in Goto-Kakizaki rats.Superior appetite hormone profile after equivalent weight loss by gastric bypass compared to gastric banding The importance of caloric restriction in the early improvements in insulin sensitivity after Roux-en-Y gastric bypass surgery Weight loss and incretin responsiveness improve glucose control independently after gastric bypass surgery.Rise of oxyntomodulin in response to oral glucose after gastric bypass surgery in patients with type 2 diabetes Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Soc Resolution of type 2 diabetes following bariatric surgery: implications for adults and adolescents.Ileal interposition improves glucose tolerance and insulin sensitivity in the obese Zucker rat.Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol.Improvement in ß-cell function in patients with normal and hyperglycemia following Roux-en-Y gastric bypass surgery.Metabolic surgery: the role of the gastrointestinal tract in diabetes mellitus.

P2860

Q24563430-16DFC641-ECBB-4FD9-9F03-0EB71F203843 Q26780440-1F487B5E-F810-4BFC-89EB-80D44B53A67C Q26865399-4CF9E0AE-9DB5-4C8F-B3B9-994BD2975194 Q26991653-BB25A7C4-4F1B-4927-80D7-616EC998331A Q26995145-0186DF50-E7FA-4A43-8545-BFB05E4D10AF Q27010589-245069A9-A892-4DB9-B523-A8B0542D7A4A Q27011627-064FBD82-45D8-4E03-8847-2AC598A7FE3A Q27022123-822C3390-8717-43A4-9295-48592E88C229 Q27026687-55FA8AE1-D5F8-4300-91FD-5C099CB9A9F8 Q27026927-04C7C556-5157-4675-8D0D-89A977090CF1 Q30277979-ADA16F0C-022E-4214-BCA6-70AAB04D5AC9 Q30351930-15277A48-DCD0-41BE-A39C-454460A4593B Q30388925-813ED980-A87F-4551-BEE2-BD531E46B9B9 Q30391329-97593118-C8E5-4874-B45D-D05B5B4F322C Q30394286-A2738BEB-4D47-48CD-A67B-9B969A93F85D Q30405974-760CB5BA-7066-4AC9-ADB1-35432C1ED012 Q33165603-B755176A-67A4-45A9-B62E-0AFCE570B29F Q33569986-9D7B7E52-9DEB-47C4-9A7B-8651781BE8F1 Q33602173-C4E9F1BA-5294-4554-B3D1-30D4C9A93277 Q33682506-48A76310-0CD1-4856-A23A-55BD99E12373 Q33696549-8CCF44B3-0435-4F56-827B-9DE897537A1E Q33711409-CEAB8C48-D461-4F4C-8EE3-0B84A867EC07 Q33743998-2BD160DE-5FB1-4C6B-9E9F-7554CD026536 Q33752066-B66AA032-F6EF-4F49-BABA-2A1C1939EBCB Q33761529-39E74370-6A2B-4D60-9EA6-A1D85BE5444B Q33772412-FC5568C1-0DE9-4004-B708-6486087D5A1F Q33789529-BF4010CD-73B7-463F-8839-2D066CB89D7E Q33816658-FDEE7548-6D7E-4B0D-896C-EA155C3F0BAB Q33838154-53B7DD87-7007-433D-87C9-37AAAA8408F7 Q33844168-AFC7E58E-7C43-4D4E-9F56-3F8285535BDB Q33879265-2D27A0D2-E4C7-4CA0-B936-66FCF201E11F Q33932609-63765758-5307-47C8-8DB0-EB1A6373281B Q34022466-25E0F3C6-E48E-4DDA-8A7C-5A831E6E4E76 Q34032014-0263E447-D3F0-433F-9AC3-826529A061B4 Q34075016-24B6A46D-BA1B-41B8-9A1E-D65211A5202A Q34113935-A26571BB-FE48-48B6-BE65-671972DF3FF6 Q34178868-6B4578A9-C484-4477-86A1-84B99BAA08AB Q34191173-F2DA5915-508D-4C9D-8C45-C81A1157BEBF Q34305172-43FD1AD4-B2B2-4870-8FBE-5F8AD1BF5D15 Q34392834-1E4CD921-66A7-45BF-8050-4D8BCB9FFE59

P2860

Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes.

http://www.wikidata.org/entity/Q36755303

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Effect of weight loss by gastr ...... patients with type 2 diabetes.

@ast

Effect of weight loss by gastr ...... patients with type 2 diabetes.

@en

type

label

Effect of weight loss by gastr ...... patients with type 2 diabetes.

@ast

Effect of weight loss by gastr ...... patients with type 2 diabetes.

@en

prefLabel

Effect of weight loss by gastr ...... patients with type 2 diabetes.

@ast

Effect of weight loss by gastr ...... patients with type 2 diabetes.

@en

P1433

Q36755303-4BE23C3F-BFDF-41B5-8CE9-53AE18A58D8C

P1476

Q36755303-335F8993-FC66-48F7-AEB7-8438214F91BC

P2093

Q36755303-18BE11E7-2FBF-43AB-9CD6-72F141DF8967

Q36755303-343C1378-F08A-45A7-8AC4-BD05D8CD86A7

Q36755303-3C1F4E03-EC4F-43AD-8F9F-4EBCE7150B43

Q36755303-3D580A29-D221-4831-8B6A-462E7D554411

Q36755303-4F43BC45-2FF4-4327-A7EB-5CC0C6953D3A

Q36755303-6D3EEE57-8BFE-405E-B3F2-9A4D5D44802F

Q36755303-8D8410F2-0DED-431D-8E16-BF94030872E5

Q36755303-94460685-A829-4968-A719-56C30EB13C72

Q36755303-BDC45203-4A9E-4BBE-935C-601954D00269

Q36755303-C324CF7E-1910-454B-884C-4B7E90CCD3A5

P2860

Q36755303-03FA92AA-F5EA-4E14-A707-2F6430E2CCCA

Q36755303-059C4D92-6957-4E59-BCDA-0F0F7EAA59FC

Q36755303-15CDF8A9-C523-4254-A89C-0DAA96F267CD

Q36755303-1770AC45-9D55-47C4-AC8F-45197A3FE39F

Q36755303-23101041-FC61-4A47-ABCE-EC4992B283B8

Q36755303-2554C966-286C-4D06-BF08-65AB6913265E

Q36755303-3721F337-6051-4E14-9D8C-32EB604B8945

Q36755303-3EA2C69C-4484-471D-A84D-00EB951E0CA8

Q36755303-3F18D324-7613-4371-8C23-551308F45306

Q36755303-44807832-D63D-4085-BCC1-C3CA896AD8A6

P304

Q36755303-8E1A8EA8-D7CF-4DB6-84E0-515226AE0509

P31

Q36755303-D1E343BC-1ECF-4EBC-802B-926903BD0F9B

P356

Q36755303-E3A34B98-DD85-46DE-B370-1A9CEC55C9AE

P407

Q36755303-5D14BD43-B018-4FFB-8474-FE2F13E7C6FA

P433

Q36755303-AEDD10D2-FBF1-4540-99AB-E308AACF6912

P478

Q36755303-E46510E6-CABF-4DA8-9099-56B57B96A321

P577

Q36755303-A8732EB0-B572-4C99-8210-0C87C7CCF539

P5875

Q36755303-32B87C83-76F1-411E-A60F-20DC1E9C08A8

P698

Q36755303-0A68786F-5911-4834-8117-A294464157FA

P921

Q36755303-2EC29D86-889C-4FAE-A062-81F0E00ACF2C

P932

Q36755303-79AE94BA-1C41-4FC5-94E4-687271CB1302

P356

P1433

The Journal of Clinical Endocrinology and Metabolism

P1476

Effect of weight loss by gastr ...... patients with type 2 diabetes.

@en

P2093

Antonia Colarusso

http://www.w3.org/2001/XMLSchema#string

Baani Bawa

http://www.w3.org/2001/XMLSchema#string

Betty Kovack

http://www.w3.org/2001/XMLSchema#string

Blanca Olivan

http://www.w3.org/2001/XMLSchema#string

Blandine Laferrère

http://www.w3.org/2001/XMLSchema#string

Hao Tran

http://www.w3.org/2001/XMLSchema#string

Hongchan Lee

http://www.w3.org/2001/XMLSchema#string

James McGinty

http://www.w3.org/2001/XMLSchema#string

Joseph R Egger

http://www.w3.org/2001/XMLSchema#string

Julio Teixeira

http://www.w3.org/2001/XMLSchema#string

P2860

Duodenal-jejunal bypass for the treatment of type 2 diabetes in patients with body mass index of 22-34 kg/m2: a report of 2 cases

The Physiology of Glucagon-like Peptide 1

Bariatric surgery: a systematic review and meta-analysis.

Postprandial glucose regulation: new data and new implications.

Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP.

Trends in mortality in bariatric surgery: a systematic review and meta-analysis.

Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002.

Highly variable gastric emptying in patients with insulin dependent diabetes mellitus.

Attenuated GLP-1 secretion in obesity: cause or consequence?

Absorption of glucose, sodium, and water by the human jejunum studied by intestinal perfusion with a proximal occluding balloon and at variable flow rates.

P304

2479-2485

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1210/JC.2007-2851

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

93

http://www.w3.org/2001/XMLSchema#string

P577

2008-04-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5421666

http://www.w3.org/2001/XMLSchema#string

P698

18430778

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

2453054

http://www.w3.org/2001/XMLSchema#string